Abstract
With the goal of overcoming multidrug resistance, DSPE-PEG (polyethylene glycol 2000 grafted with distearoyl phosphatidylethanolamine) and TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) were combined, each with a different inhibiting mechanism for P-glycoprotein (P-gp) expression, to create mixed micelles with the purpose of encapsulating the water-soluble drug, doxorubicin (Dox). As the molar ratio of Dox/DSPE-PEG/TPGS was 1:1:0.2, the encapsulation efficiency and particle size of the micelles were 98.2% and 12.8 nm respectively. Compared to Dox/DSPE-PEG micelles, Dox/DSPE-PEG/TPGS mixed micelles demonstrated enhanced in vitro cytotoxicity, drug uptake, and apoptosis for drug resistant H460/TaxR cancer cells. Western blot results showed that the expression level of P-gp significantly decreased as H460/TaxR cells were incubated with Dox/DSPE-PEG/TPGS mixed micelles. The anti-tumor efficacy in vivo was evaluated using H460/TaxR-bearing mice and showed that Dox/DSPE-PEG/TPGS mixed micelles were more effective at inhibiting tumor growth than Dox/DSPE-PEG micelles and free Dox solution. It was also found that the high efficacy of mixed micelles was associated with the ability to induce dramatic apoptosis of the tumor cells. In summary, through combining different P-gp inhibiting mechanisms, mixed micelles could be a promising nanocarrier for anti-cancer drugs in overcoming multidrug resistance.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
